Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection

Rabbit anti-thymocyte globulin (rATG) is currently the treatment of choice for glucocorticoid-resistant, recurrent, or severe acute allograft rejection (AR). However, rATG is associated with severe infusion-related side effects. Alemtuzumab is incidentally given to kidney transplant recipients as tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: van der Zwan, Marieke, Clahsen-Van Groningen, Marian C., van den Hoogen, Martijn W. F., Kho, Marcia M. L., Roodnat, Joke I., Mauff, Katya A. L., Roelen, Dave L., van Agteren, Madelon, Baan, Carla C., Hesselink, Dennis A.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350932/
https://ncbi.nlm.nih.gov/pubmed/32719676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01332
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars